La Roche-Posay Anthelios Ultra BB Cream SPF 50+ 50ml

Exceptionally high protection facial sunscreen in a moisturising cream texture for dry to very dry skin. Tinted for a natural-looking glow.

SPECIFICALLY FORMULATED FOR

This sunscreen is specifically formulated for the face and is suitable for dry to very dry skin that is prone to sensitivity, sun-intolerance or prickly-heat. This luxuriously moisturising, very high protection formula is specifically formulated for the face with a natural tint for a light, natural glow.

• A facial sunscreen for dry skin that is fair and prone to sun sensitivity


• Broad, photostable UVA/UVB & Infrared protection


• With a sheer tint for light coverage and a natural glow

ACTIVE INGREDIENTS

Exceptionally high, broad photostable UVA/UVB/Infrared protection. Optimal SPF 50+ protection reinforced against UVA rays (stricter than the European recommendation) thanks to patented filtering system Mexoplex® combined with La Roche-Posay Thermal Spring Water.

DERMATOLOGICALLY TESTED

Anthelios efficacy has been demonstrated via clinical studies carried out in-vivo on subjects suffering from sun intolerances, particularly those caused by UVA rays. Anthelios products all have a high PPD (Persistent Pigment Darkening) factor, offering one of the best protections against UVA offered by any brand in the world. The efficacy has been proven by a file of 16 clinical studies carried out by world-renowned expert dermatologists. The brand was also the first laboratory to use Mexoryl XL and Mexoryl SX and the first to use photostable UVA filters in its sun protection.

9/10 of dermatologists would recommend Anthelios*

MINIMALIST HYPO-ALLERGENIC FORMULA

The minimalist formula contains the best of our creations – designed for sensitive skin and all of its needs. Tested and re-tested for its efficacy and mildness on sensitive skin. It is also hypoallergenic.

This is a cosmetic product. For medical conditions seek advice from your GP

*Survey conducted on 249 dermatologists who chose to attend a La Roche-Posay sponsored symposium in the UK, July 2016